Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines

Journal of Medicinal Chemistry

Volumn 50, Issue 6, 2007, Pages 1316-1321

  Thomadaki, Hellinida ^a   Karaliota, Alexandra ^a   Litos, Charalambos ^a   Scorilas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIHYDROXYBENZOATE MOLYBDENUM; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTILEUKEMIC AGENT; GENTISIC ACID; MOLYBDENUM COMPLEX; TETRAPHENYLPHOSPHONIUM; TETRAPHENYLPHOSPHONIUM POLYOXOMOLYBDENUM; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL MEMBRANE; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENTISATES; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA, MYELOID; MAGNETIC RESONANCE SPECTROSCOPY; NECROSIS; ONIUM COMPOUNDS; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33947683157     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0610797     Document Type: Article

References (31)

1. Liu, S.; Edwards, D. S. Stabilization of 90Y-labeled DOTA-biomolecule conjugates using gentisic acid and ascorbic acid. Bioconjugate Chem. 2001, 12, 554-558.
2. Sharma, S.; Khan, N.; Sultana, S. Modulatory effect of gentisic acid on the augmentation of biochemical events of tumor promotion stage by benzoyl peroxide and ultraviolet radiation in Swiss albino mice. Toxicol. Lett. 2004, 153, 293-302.
3. 2 synthesis in murine macrophages. Biochem. Biophys. Res. Commun. 2000, 274, 197-202.
4. Yeh, C.-T.; Huang, S.-M.; Yen, G.-C. Induction of phenolsulfotrans-ferase expression by phenolic acids in human hepatoma HepG2 cells. J. Agric. Food Chem. 2005, 53, 4766-4773.
5. Sharma, S.; Khan, N.; Sultana, S. Study on prevention of two-stage skin carcinogenesis by Hibiscus rosa sinensis extract and the role of its chemical constituent, gentisic acid, in the inhibition of tumour promotion response and oxidative stress in mice. Eur. J. Cancer Prev. 2004, 13, 53-63.
6. Feix, J. B.; Anderson, M. S.; Kalyanaraman, B. Enhancement of merocyanine-540 uptake and photodynamic cell-killing by salicylates. Cancer Res. 1994, 54, 3474-3478.
7. Anderson, M. S.; Kalyanaraman, B.; Feix, J. B. Enhancement of merocyanine-540 uptake and photodynamic cell-killing by salicylates. Cancer Res. 1993, 53, 806-809.
8. Ogata, A.; Mitsui, S.; Yanagie, H.; Kasano, H.; Hisa, T.; Yamase, T.; Eriguchi, M. A novel anti-tumor agent, polyoxomolybdate, induces apoptotic cell death in AsPC-1 human pancreatic cancer cells. Biomed. Pharmacother. 2005, 59, 240-244.
9. Fujita, H.; Fujita, T.; Sakurai, T.; Yamase, T.; Seto, Y. Antitumor activity of new antitumor substance, polyoxomolybdate, against several human cancers in athymic nude-mice. Tohoku J. Exp. Med. 1992, 168, 421-426.
10. 2-. Chin. J. Chem. 2005, 23, 781-785.
11. Redman, B. G.; Esper, P.; Pan, Q.; Dunn, R. L.; Hussain, H. K.; Chenevert, T.; Brewer, G. J.; Merajver, S. F. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin. Cancer Res. 2003, 9, 1666-1672.
12. Seaborn, C. D.; Yang, S. P. Effect of molybdenum supplementation on N-nitroso-N-methylurea-induced mammary carginogenesis and molybdenum excretion in rats. Biol. Trace Elem. Res. 1993, 39, 245-256.
13. Rideout, D.; Bustamante, A.; Patel, J. Mechanism of inhibition of FADU hypopharyngeal carcinoma cell-growth by tetraphenylphosphonium chloride. Int. J. Cancer 1994, 57, 247-253.
14. Lampidis, T. J.; Hasin, Y.; Weiss, M. J.; Chen, L. B. Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: A cellular basis. Biomed. Pharmacother. 1985, 39, 220-226.
15. Wujcik, D. Molecular biology of leukemia. Semin. Oncol. Nurs. 2003, 19, 83-89.
16. Reed, J. C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 1999, 17, 2941-2953.
17. Seller, W. R.; Fisher, D. E. Apoptosis and cancer drug targeting. J. Clin. Invest. 1999, 104, 1655-1661.
18. Fisher, D. E. Apoptosis in cancer therapy: Crossing the threshold. Cell 1994, 78, 539-542.
19. Kerr, J. F.; Winterford, C. M.; Harmon, B. V. Apoptosis. Its significance in cancer and cancer chemotherapy. Cancer 1994, 73, 2013-2026.
20. Belamy, C. O.; Malcomson, R. D.; Harrison, D. J.; Wyllie, A. H. Cell death in health and disease:the biology and regulation of apoptosis. Semin. Cancer Biol. 1995, 6, 3-16.
21. McDonnell, T. J.; Meyn, R. E.; Robertson, L. E. Implications of apoptosis cell death regulation in cancer therapy. Semin. Cancer Biol. 1995, 6, 3-16.
22. Eastman, A. Survival factors, intracellular signal transduction and the activation of endonucleases in apoptosis. Cancer Biol. 1995, 6, 53-60.
23. Shah, A. M.; Schwartz, G. K. Cell cycle-mediated drug resistance: An emerging concept in cancer therapy. Clin. Cancer Res. 2001, 7, 2168-2181.
24. Kanduc, D.; Mittelman, A.; Serpico, R.; Sinigaglia, E.; Sinha, A. A.; Natale, C.; Santacroce, R.; Di Corcia, M. G.; Lucchese, A.; Dini, L.; Pani, P.; Santacroce, S.; Simone, S.; Bucci, R.; Farber, E. Cell death: Apoptosis versus necrosis. Int. J. Oncol. 2002, 21, 165-170.
25. Floros, K. V.; Thomadaki, H.; Lallas, G.; Katsaros, N.; Talieri, M.; Scorilas, A. Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12. Ann. N. Y. Acad. Sci. 2003, 1010, 153-158.
26. Floras, K. V.; Thomadaki, H.; Katsaros, N.; Talieri, M.; Scorilas, A. mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol. Chem. 2004, 385, 1099-1103.
27. Thomadaki, H.; Tsiapalis, C. M.; Scorilas, A. Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biol. Chem. 2005, 386, 471-480.
28. Floros, K. V.; Thomadaki, H.; Florou, D.; Talieri, M.; Scorilas, A. Alterations in the mRNA expression of the apoptosis-related genes BCL2, BAX, FAS, CASPASE-3, and the novel member, BCL2L12, after treatment of human leukemic cell line HL60 with the antineoplasitic agent etoposide. Ann. N. Y. Acad. Sci. 2006, 1090, 89-97.
29. Thomadaki, H.; Scorilas, A. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin and doxorubicin, at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann. N. Y. Acad. Sci. 2007, 1095, in press.
30. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
31. Freshney, R. Culture of Animal Cells: A Manual of Basic Technique; Alan R. Liss, Inc.: New York, 1987; p 117.